Mucosal vaccine development based on liposome technology
V Bernasconi, K Norling, M Bally… - Journal of …, 2016 - Wiley Online Library
Immune protection against infectious diseases is most effective if located at the portal of
entry of the pathogen. Hence, there is an increasing demand for vaccine formulations that …
entry of the pathogen. Hence, there is an increasing demand for vaccine formulations that …
[HTML][HTML] Mucosal Vaccine Development Based on Liposome Technology
V Bernasconi, K Norling, M Bally, F Höök… - Journal of Immunology …, 2016 - ncbi.nlm.nih.gov
Immune protection against infectious diseases is most effective if located at the portal of
entry of the pathogen. Hence, there is an increasing demand for vaccine formulations that …
entry of the pathogen. Hence, there is an increasing demand for vaccine formulations that …
[PDF][PDF] Mucosal Vaccine Development Based on Liposome Technology
V Bernasconi, K Norling, M Bally, F Höök, NY Lycke - 2016 - academia.edu
Immune protection against infectious diseases is most effective if located at the portal of
entry of the pathogen. Hence, there is an increasing demand for vaccine formulations that …
entry of the pathogen. Hence, there is an increasing demand for vaccine formulations that …
[PDF][PDF] Mucosal Vaccine Development Based on Liposome Technology
V Bernasconi, K Norling, M Bally, F Höök, NY Lycke - 2016 - pdfs.semanticscholar.org
Immune protection against infectious diseases is most effective if located at the portal of
entry of the pathogen. Hence, there is an increasing demand for vaccine formulations that …
entry of the pathogen. Hence, there is an increasing demand for vaccine formulations that …
[PDF][PDF] Mucosal Vaccine Development Based on Liposome Technology
V Bernasconi, K Norling, M Bally, F Höök, NY Lycke - 2016 - researchgate.net
Immune protection against infectious diseases is most effective if located at the portal of
entry of the pathogen. Hence, there is an increasing demand for vaccine formulations that …
entry of the pathogen. Hence, there is an increasing demand for vaccine formulations that …
Mucosal Vaccine Development Based on Liposome Technology
V Bernasconi, K Norling, M Bally, F Hook… - Journal of Immunology …, 2017 - go.gale.com
Immune protection against infectious diseases is most effective if located at the portal of
entry of the pathogen. Hence, there is an increasing demand for vaccine formulations that …
entry of the pathogen. Hence, there is an increasing demand for vaccine formulations that …
Mucosal Vaccine Development Based on Liposome Technology
V Bernasconi, K Norling, M Bally, F Höök… - Journal of Immunology …, 2016 - cir.nii.ac.jp
抄録< jats: p> Immune protection against infectious diseases is most effective if located at
the portal of entry of the pathogen. Hence, there is an increasing demand for vaccine …
the portal of entry of the pathogen. Hence, there is an increasing demand for vaccine …
[PDF][PDF] Mucosal Vaccine Development Based on Liposome Technology
V Bernasconi, K Norling, M Bally, F Höök, NY Lycke - 2016 - research.chalmers.se
Immune protection against infectious diseases is most effective if located at the portal of
entry of the pathogen. Hence, there is an increasing demand for vaccine formulations that …
entry of the pathogen. Hence, there is an increasing demand for vaccine formulations that …
Mucosal Vaccine Development Based on Liposome Technology
V Bernasconi, K Norling, M Bally… - Journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Immune protection against infectious diseases is most effective if located at the portal of
entry of the pathogen. Hence, there is an increasing demand for vaccine formulations that …
entry of the pathogen. Hence, there is an increasing demand for vaccine formulations that …
Mucosal Vaccine Development Based on Liposome Technology.
V Bernasconi, K Norling, M Bally… - Journal of …, 2016 - search.ebscohost.com
Immune protection against infectious diseases is most effective if located at the portal of
entry of the pathogen. Hence, there is an increasing demand for vaccine formulations that …
entry of the pathogen. Hence, there is an increasing demand for vaccine formulations that …